Odimma is a French biotech company with a unique approach
in active personalized cancer immunotherapy.
Odimma believes in the future of precision medicine, and leverages recent advances
in the field of immuno-oncology to fight the most hard-to-treat cancers.
By harnessing the ability of the patient’s own immune system
to specifically recognize non-self-targets displayed by the tumor, also called neoantigens,
Odimma...
Odimma is a French biotech company with a unique approach
in active personalized cancer immunotherapy.
Odimma believes in the future of precision medicine, and leverages recent advances
in the field of immuno-oncology to fight the most hard-to-treat cancers.
By harnessing the ability of the patient’s own immune system
to specifically recognize non-self-targets displayed by the tumor, also called neoantigens,
Odimma has designed a potent next-generation personalized immunization platform.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.